The massive EPS beat and margin expansion validate Philips' restructuring and productivity initiatives. With full-year guidance reiterated and strong order intake, the stock should re-rate higher. Watch for continued execution on the 2026-2028 productivity program and any tariff-related updates in the next quarter.
Price Chart
Executive Summary
Philips reported Q1 2026 EPS of $0.50, a 165.3% beat vs $0.19 consensus, on revenue of EUR 3.9B (+4% comparable sales growth). Adjusted EBITA margin expanded 40 bps to 9.0%, and the company reiterated its full-year 2026 outlook for 3%-4.5% comparable sales growth and 12.5%-13.0% adjusted EBITA margin. The strong earnings beat and margin expansion signal improving operational execution despite tariff headwinds.
Key Financial Metrics
Key Facts
- Q1 2026 EPS of $0.50 vs consensus $0.19 (165.3% beat)
- Q1 2026 revenue EUR 3.9B, +4% comparable sales growth
- Adjusted EBITA margin expanded 40 bps to 9.0%
- Comparable order intake grew 6%, led by Diagnosis & Treatment and Connected Care
- Free cash flow EUR 28M in Q1
- Full-year 2026 outlook reiterated: 3%-4.5% comparable sales growth, 12.5%-13.0% adjusted EBITA margin, FCF EUR 1.3-1.5B
- Productivity savings of EUR 126M in Q1; on track for EUR 1.5B under 2026-2028 program
- Personal Health segment led growth with +9% comparable sales; margin up 60 bps to 15.8%
- Diagnosis & Treatment comparable sales +2%, margin +30 bps to 9.8%
- Connected Care comparable sales +3%, margin -60 bps to 2.9% due to tariffs and cost inflation
Financial Impact
EPS beat of $0.31 vs consensus; revenue beat of ~EUR 20M vs EUR 3.88B consensus; margin expansion of 40 bps
Risk Factors
- Tariff and cost inflation headwinds persist, especially pressuring Connected Care margins
- Ongoing Philips Respironics-related legal proceedings and DOJ investigation
- Uncertain macro environment could impact demand and supply chain
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3288473 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 27, 2026 5w ago | Press Release | $26.92 $24.55 | ▼ −8.80% | ▼ −8.30% | $23.92 (−11.14%) |
Aug 24, 2026 5w ago | Press Release | $27.43 $24.90 | ▼ −9.22% | ▼ −10.47% | $23.92 (−12.80%) |
Jul 27, 2026 9w ago | Press Release | $25.02 $27.52 | ▲ +9.99% | ▲ +6.69% | $23.92 (−4.40%) |
Jun 2, 2026 17w ago | Press Release | $25.43 $27.20 | ▲ +6.96% | ▲ +8.53% | $23.92 (−5.94%) |
May 15, 2026 20w ago | Court Ruling | $25.23 $26.69 | ▲ +5.79% | ▲ +3.67% | $23.92 (−5.19%) |
May 6, 2026 21w ago | Press Release | $27.23 $25.35 | ▼ −6.90% | ▼ −9.69% | $23.92 (−12.16%) |
Mar 23, 2026 27w ago | Press Release | $26.81 $28.48 | ▲ +6.23% | ▼ −1.19% | $23.92 (−10.78%) |
Feb 10, 2026 33w ago | Court Ruling | $32.91 $28.81 | ▼ −12.46% | ▼ −10.18% | $23.92 (−27.32%) |
Feb 10, 2026 33w ago | Court Ruling | $32.91 $28.81 | ▼ −12.46% | ▼ −10.18% | $23.92 (−27.32%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access